337 related articles for article (PubMed ID: 19712456)
21. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
[TBL] [Abstract][Full Text] [Related]
22. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
[TBL] [Abstract][Full Text] [Related]
24. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy.
Ascherl G; Hohenadl C; Schatz O; Shumay E; Bogner J; Eckhart L; Tschachler E; Monini P; Ensoli B; Stürzl M
Blood; 1999 Jun; 93(12):4232-41. PubMed ID: 10361120
[TBL] [Abstract][Full Text] [Related]
25. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
26. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Marginean A; Sharma-Walia N
Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
[TBL] [Abstract][Full Text] [Related]
27. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.
Lane BR; Liu J; Bock PJ; Schols D; Coffey MJ; Strieter RM; Polverini PJ; Markovitz DM
J Virol; 2002 Nov; 76(22):11570-83. PubMed ID: 12388718
[TBL] [Abstract][Full Text] [Related]
29. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Arastéh K; Hannah A
Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.
Taraboletti G; Benelli R; Borsotti P; Rusnati M; Presta M; Giavazzi R; Ruco L; Albini A
J Pathol; 1999 May; 188(1):76-81. PubMed ID: 10398144
[TBL] [Abstract][Full Text] [Related]
31. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
[TBL] [Abstract][Full Text] [Related]
32. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
33. Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity.
Scheidegger P; Weiglhofer W; Suarez S; Console S; Waltenberger J; Pepper MS; Jaussi R; Ballmer-Hofer K
Biochem J; 2001 Feb; 353(Pt 3):569-78. PubMed ID: 11171054
[TBL] [Abstract][Full Text] [Related]
34. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study.
Rasheed S; Yan JS; Lau A; Chan AS
PLoS One; 2008 Aug; 3(8):e3003. PubMed ID: 18714345
[TBL] [Abstract][Full Text] [Related]
35. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
36. Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor.
Chen L; Feng Z; Yuan G; Emerson CC; Stewart PL; Ye F; Jin G
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051269
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
38. Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein.
Rusnati M; Urbinati C; Musulin B; Ribatti D; Albini A; Noonan D; Marchisone C; Waltenberger J; Presta M
Endothelium; 2001; 8(1):65-74. PubMed ID: 11409852
[TBL] [Abstract][Full Text] [Related]
39. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
Murakami-Mori K; Mori S; Bonavida B; Nakamura S
J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
[TBL] [Abstract][Full Text] [Related]
40. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
